Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Drug Dosing and Estimated Renal Function - Any Step Forward from Effersoe?

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Glomerular Filtration Rate Estimation in Renal and Non-Renal Solid Organ Transplantation

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Urinary excretion of Tamm-Horsfall protein and epidermal growth factor in chronic nephropathy

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Exercise training and the progression of chronic renal failure

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Reduced erythrocyte lifespan measured by chromium-51 in patients with type 2 diabetes undergoing long-term hemodialysis

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. One-year mortality increases four-fold in frail patients undergoing cardiac surgery

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Rodent models of diabetic kidney disease: human translatability and preclinical validity

    Research output: Contribution to journalReviewpeer-review

  4. The Glycemic Effect of Liraglutide Evaluated by Continuous Glucose Monitoring in Persons with Type 2 Diabetes Receiving Dialysis

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Drug dosing in accordance with the renal function is a long-standing challenge to clinicians. For many years it has been evident that in many clinical situations there is no easy way to correctly dose any drug that is mainly cleared by the kidneys. Despite the development of many formulas for estimating the glomerular filtration rate, they all have serious shortcomings. Much effort has been put in to develop estimation formulas to evaluate the renal function as an alternative to direct methods with the aim of safely dosing drugs that are mainly cleared by the kidneys. Both creatinine- and cystatin C-based formulas with additional clinical and biochemical parameters deduced from association studies with methods to measure the glomerular filtration rate (mGFR) have been developed. None of them have been good enough to perform safely in the wide range of situations in daily clinical praxis. Despite serious limitations, there has also been a tendency to use estimated GFR (eGFR) as a "hard" clinical endpoint in clinical studies. This has increased the risk of misinterpretation and has led to conclusions that are not necessarily supported by data. Finally, new methods of testing drug toxicity and the use of pharmacological support in order to fix the right doses are mentioned in this short overview of studies; possible problems that are encountered using eGFR instead of mGFR in the clinic and in research are also mentioned in this report.

Original languageEnglish
JournalNephron
Volume136
Issue number4
Pages (from-to)268-272
Number of pages5
ISSN0028-2766
DOIs
Publication statusPublished - 2017

    Research areas

  • Journal Article

ID: 52424326